Alnylam's $250 million investment will enhance its Norton, Massachusetts facility with an enzymatic ligation platform to meet global RNAi therapeutics demand. The expansion supports Alnylam's pipeline ...

New platform is expected to substantially increase manufacturing capacity and lower production costs, enabling investment in expanding pipeline FDA has accepted Alnylam’s enzymatic ligation ...

Nucleic acid-based therapies enable precise gene modulation, offering new treatment possibilities for undruggable diseases, with development hinging on optimizing bioconjugation and bioanalysis.

NEW YORK – Backed by promising results from a recent small study, Arima Genomics believes that its Hi-C lymphoma assay can eventually replace fluorescence in situ hybridization (FISH)-based tests to ...

Contract development and manufacturing organization (CDMO) Alcami has announced plans to expand its laboratory services footprint in Durham, North Carolina, to address growing demand for biologics.

Center for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States Nanoscience Initiative at Advanced Science Research Center, Graduate ...

This fundamental manuscript presents a practical modification of the orthogonal hybridization chain reaction (HCR) technique, a promising yet underutilized method with broad potential for future ...

Multiplex qPCR is a popular area of interest for many assay developers. Thanks to distinct reporter dyes, multiple reactions can be combined into a single well, with each target detected independently ...

Background: Atherosclerosis (AS) is an important cause of cardiovascular and cerebrovascular diseases. Inflammation and autophagy play important roles in the occurrence and progression of AS. The ...